chartexchange

Leading Australian fertility group Genea to run first independent clinical study of JUNO-Checked

Cision | Nov 9, 2026 2:06 AM EST

Spermosens AB has signed a collaboration framework agreement with Genea Pty Ltd (Genea), one of Australia's leading fertility groups, which plans to conduct an independent clinical study of the Company's JUNO-Checked diagnostic in IVF cycles, subject to ethics approval and a separate study agreement. This is the first time JUNO-Checked will be evaluated by an external clinic group.
Male factor contributes to around half of all infertility cases, yet standard semen analysis says little about whether sperm can bind to and fertilize an egg. JUNO-Checked measures sperm binding to JUNO, the

Read original article